Krystal Biotech delivered strong Q1 2026 results, with Vyjuvek sales up 32% YoY to $116.4M and gross margin expanding to 95%.

JNJ-4804 demonstrated highest rates of clinical and endoscopic outcomes compared to golimumab and guselkumab in patients with ulcerative colitis or Crohn's disease ...

ALLEN COUNTY, Ind. (WANE) – A new nonprofit that supports students and staff in Northwest Allen County Schools now has a group dedicated to continuing that mission. Liz Hathaway, President, Northwest ...

Almost two years after her murder, Winona resident Madeline Kingsbury is being honored in a new way through a foundation set up by her loved ones. The disappearance of Winona resident Madeline ...

Microsoft last week set the record straight that Web Forms, part of ASP.NET from the old .NET Framework, isn't going away in Visual Studio 2022, though it recommends Blazor as a .NET 6 alternative. It ...

Q VYJUVEK global revenue and $846.7 million since launchEnrollment complete in KB803 (corneal abrasions in DEB patients) ...

Forbes contributors publish independent expert analyses and insights. Ashley L. Case, J.D., LL.M., writes about tax and estate planning. Form 56 serves as a conduit of communication between taxpayers ...

Bristol Myers Squibb today announced that the European Commission has granted approval to Sotyktu (deucravacitinib), alone or in combination with methotrexate, for the treatment of active psoriatic ...

Rogers Communications' $18B Sports Portfolio, Churchill Downs' $85M Acquisition, Lewis Hamilton's New Collectibles Venture ...

Johnson & Johnson today announced results from the Phase 3 FUZION study evaluating TREMFYA® (guselkumab) in adults with active perianal fistulizing Crohn's disease (CD). At Week 24, TREMFYA ...

Most construction contracts in India often include clauses that restrict or completely negate a contractor's right to seek ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Broad form insurance covers rare risks not included in basic insurance, often requiring ...